All Stories

  1. Endotypes in allergic diseases
  2. ARIA 2016 executive summary: Integrated care pathways for predictive, preventive and personalized medicine across the life cycle
  3. EAACI Guidelines on Allergen Immunotherapy - Out With the Old and In With the New
  4. Monitoring the inflammatory heterogeneity in asthma with multiple biomarkers for multidimensional endotyping
  5. Comprehensive characterization of asthma patients using the Bayesian Network Model
  6. Asthma Biomarkers: Do They Bring Precision Medicine Closer to the Clinic?
  7. Serum IL-5 and IL-13 consistently serve as the best predictors for the blood eosinophilia phenotype in adult asthmatics
  8. Endotypes of allergic diseases and asthma: An important step in building blocks for the future of precision medicine
  9. Non-eosinophilic Asthma Endotypes
  10. EAACI Food Allergy and Anaphylaxis Guidelines: managing patients with food allergy in the community
  11. Endotype Driven Treatment of Asthma
  12. Recommendations for the allergy management in the primary care
  13. Sputum Cytokines and Adult Asthma Endotypes
  14. Primary prevention of food allergy in children and adults: systematic review
  15. Acute and long-term management of food allergy: systematic review
  16. Improving allergy management in the primary care network - a holistic approach
  17. Allergy management in primary care across European countries – actual status
  18. From phenotypes to endotypes to asthma treatment
  19. Weight loss interventions in asthma: EAACI Evidence‐Based Clinical Practice Guideline (Part I)
  20. A direct comparison of efficacy between desloratadine and rupatadine in seasonal allergic rhinoconjunctivitis: a randomized, double-blind, placebo-controlled study
  21. Longitudinal Evaluation of the Prognostic Value for Difficult Asthma of Rhinitis Clusters
  22. Management of hypersensivity pneumonitis
  23. Mechanisms of Allergen-Specific Immunotherapy and Novel Ways for Vaccine Development
  24. Allergic Rhinitis and its Impact on Asthma (ARIA): Achievements in 10 years and future needs
  25. Dysfunctional breathing phenotype in adults with asthma ‐ incidence and risk factors
  26. Research needs in allergy: an EAACI position paper, in collaboration with EFA
  27. Severe Chronic Allergic (and Related) Diseases: A Uniform Approach – A MeDALL – GA<sup>2</sup>LEN – ARIA Position Paper
  28. Risk Factors and Asthma Phenotypes in Children and Adults with Seasonal Allergic Rhinitis
  29. Viruses and bacteria in acute asthma exacerbations – A GA2LEN‐DARE* systematic review
  30. Increased serum IL-17 is an independent risk factor for severe asthma
  31. Efficacy and safety of bilastine 20 mg compared with cetirizine 10 mg and placebo for the symptomatic treatment of seasonal allergic rhinitis: a randomized, double‐blind, parallel‐group study
  32. A 12‐week placebo‐controlled study of rupatadine 10 mg once daily compared with cetirizine 10 mg once daily, in the treatment of persistent allergic rhinitis
  33. Antinuclear Antibodies in Asthma are Correlated with Lack of Asthma Control